|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-2-17
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Critical limb ischemia due to peripheral arterial occlusive disease is associated with a severely increased morbidity and mortality. There is no effective pharmacological therapy available. Injection of autologous bone marrow-derived mononuclear cells (BM-MNC) is a promising therapeutic option in patients with critical limb ischemia, but double-blind, randomized trials are lacking.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1941-7632
|
|
pubmed:author |
pubmed-author:BalzerJörn OJO,
pubmed-author:BaumgartnerIrisI,
pubmed-author:DimmelerStefanieS,
pubmed-author:KalkaChristophC,
pubmed-author:KrankenbergHansH,
pubmed-author:Lindhoff-LastEdelgardE,
pubmed-author:PROVASA Investigators,
pubmed-author:SchlüterMichaelM,
pubmed-author:SeegerFlorianF,
pubmed-author:TonnTorstenT,
pubmed-author:WalterDirk HDH,
pubmed-author:ZeiherAndreas MAM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
26-37
|
|
pubmed:dateRevised |
2011-8-4
|
|
pubmed:meshHeading |
pubmed-meshheading:21205939-Aged,
pubmed-meshheading:21205939-Double-Blind Method,
pubmed-meshheading:21205939-Female,
pubmed-meshheading:21205939-Humans,
pubmed-meshheading:21205939-Injections, Intra-Arterial,
pubmed-meshheading:21205939-Ischemia,
pubmed-meshheading:21205939-Lower Extremity,
pubmed-meshheading:21205939-Male,
pubmed-meshheading:21205939-Middle Aged,
pubmed-meshheading:21205939-Peripheral Arterial Disease,
pubmed-meshheading:21205939-Pilot Projects,
pubmed-meshheading:21205939-Stem Cell Transplantation,
pubmed-meshheading:21205939-Stem Cells,
pubmed-meshheading:21205939-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA).
|
|
pubmed:affiliation |
Division of Cardiology and Angiology, Department of Radiology, University of Frankfurt, Theodor-Stern Kai 7, Frankfurt, Germany. dirkhwalter@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
